234 related articles for article (PubMed ID: 34851822)
41. The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.
Bazarov AV; Lee WJ; Bazarov I; Bosire M; Hines WC; Stankovich B; Chicas A; Lowe SW; Yaswen P
Cell Cycle; 2012 Mar; 11(5):1008-13. PubMed ID: 22333593
[TBL] [Abstract][Full Text] [Related]
42. Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.
Alessio N; Bohn W; Rauchberger V; Rizzolio F; Cipollaro M; Rosemann M; Irmler M; Beckers J; Giordano A; Galderisi U
Cell Mol Life Sci; 2013 May; 70(9):1637-51. PubMed ID: 23370776
[TBL] [Abstract][Full Text] [Related]
43. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells.
Jackson JG; Pereira-Smith OM
Mol Cell Biol; 2006 Apr; 26(7):2501-10. PubMed ID: 16537896
[TBL] [Abstract][Full Text] [Related]
44. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest.
Laplantine E; Rossi F; Sahni M; Basilico C; Cobrinik D
J Cell Biol; 2002 Aug; 158(4):741-50. PubMed ID: 12177046
[TBL] [Abstract][Full Text] [Related]
45. Genomic landscape of retinoblastoma in Rb
Kooi IE; van Mil SE; MacPherson D; Mol BM; Moll AC; Meijers-Heijboer H; Kaspers GJ; Cloos J; Te Riele H; Dorsman JC
Genes Chromosomes Cancer; 2017 Mar; 56(3):231-242. PubMed ID: 27750399
[TBL] [Abstract][Full Text] [Related]
46. Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis.
Lara MF; García-Escudero R; Ruiz S; Santos M; Moral M; Martínez-Cruz AB; Segrelles C; Lorz C; Paramio JM
Mol Carcinog; 2008 Mar; 47(3):209-21. PubMed ID: 17932948
[TBL] [Abstract][Full Text] [Related]
47. The RB/p107/p130 phosphorylation pathway is not inhibited in rapamycin-induced G1-prolongation of NIH3T3 cells.
Chen Y; Knudsen ES; Wang JY
Oncogene; 1996 Oct; 13(8):1765-71. PubMed ID: 8895523
[TBL] [Abstract][Full Text] [Related]
48. Retinoblastoma protein (pRb), but not p107 or p130, is required for maintenance of enterocyte quiescence and differentiation in small intestine.
Guo J; Longshore S; Nair R; Warner BW
J Biol Chem; 2009 Jan; 284(1):134-140. PubMed ID: 18981186
[TBL] [Abstract][Full Text] [Related]
49. The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium.
Haigis K; Sage J; Glickman J; Shafer S; Jacks T
J Biol Chem; 2006 Jan; 281(1):638-47. PubMed ID: 16258171
[TBL] [Abstract][Full Text] [Related]
50. p130 mediates TGF-beta-induced cell-cycle arrest in Rb mutant HT-3 cells.
Choi HH; Jong HS; Hyun Song S; You Kim T; Kyeong Kim N; Bang YJ
Gynecol Oncol; 2002 Aug; 86(2):184-9. PubMed ID: 12144826
[TBL] [Abstract][Full Text] [Related]
51. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
Carroll JS; Prall OW; Musgrove EA; Sutherland RL
J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
[TBL] [Abstract][Full Text] [Related]
52. p107 and p130: versatile proteins with interesting pockets.
Classon M; Dyson N
Exp Cell Res; 2001 Mar; 264(1):135-47. PubMed ID: 11237530
[TBL] [Abstract][Full Text] [Related]
53. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
Leoncini L; Bellan C; Cossu A; Claudio PP; Lazzi S; Cinti C; Cevenini G; Megha T; Laurini L; Luzi P; Orcioni GF; Piccioli M; Pileri S; Giardino C; Tosi P; Giordano A
Clin Cancer Res; 1999 Dec; 5(12):4065-72. PubMed ID: 10632341
[TBL] [Abstract][Full Text] [Related]
54. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
55. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
Duan L; Perez RE; Calhoun S; Maki CG
Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
[TBL] [Abstract][Full Text] [Related]
56. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
Liu Z; Gersbach E; Zhang X; Xu X; Dong R; Lee P; Liu J; Kong B; Shao C; Wei JJ
Mol Cancer Res; 2013 Nov; 11(11):1314-25. PubMed ID: 24045973
[TBL] [Abstract][Full Text] [Related]
57. Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy.
Giordano A; Rossi A; Romano G; Bagella L
J Cell Physiol; 2007 Nov; 213(2):403-6. PubMed ID: 17708530
[TBL] [Abstract][Full Text] [Related]
58. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.
Lacy S; Whyte P
Oncogene; 1997 May; 14(20):2395-406. PubMed ID: 9188854
[TBL] [Abstract][Full Text] [Related]
59. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor.
Tomosugi M; Sowa Y; Yasuda S; Tanaka R; te Riele H; Ikawa H; Koyama M; Sakai T
Cancer Sci; 2012 Dec; 103(12):2139-43. PubMed ID: 22957647
[TBL] [Abstract][Full Text] [Related]
60. Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.
Mori A; Higashi H; Hoshikawa Y; Imamura M; Asaka M; Hatakeyama M
Oncogene; 1999 Nov; 18(46):6209-21. PubMed ID: 10597219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
